Cancer ovary, present and future of management
- PMID: 14552255
Cancer ovary, present and future of management
Erratum in
- J Ayub Med Coll Abbottabad. 2005 Jul-Sep;17(3):87. Pervez, Tariq [corrected to Parvez, Tariq]
Abstract
Ovarian cancer is very important malignancy of woman as far as its incidence and mortality is concerned. Although majority presents at late stage but still there is a reasonable response to currently available chemotherapy drugs and their use in multimodality setting. Besides good response to chemotherapy drugs, majority have recurrence. So there is a need for new drugs, new trends and their combinations. All these issues will be discussed in this review article.
Similar articles
-
[Remote results of the standard ovary cancer treatment].Voen Med Zh. 2005 Nov;326(11):36-8. Voen Med Zh. 2005. PMID: 16404905 Russian. No abstract available.
-
Advances in the management of epithelial ovarian cancer.J Reprod Med. 2005 Jun;50(6):426-38. J Reprod Med. 2005. PMID: 16050567 Review.
-
Recent advances in the management of women with ovarian cancer.Minerva Ginecol. 2004 Feb;56(1):81-9. Minerva Ginecol. 2004. PMID: 14973412 Review.
-
Outcome of recurrent and persistent disease of malignant ovarian germ cell tumor: a retrospective analysis at King Chulalongkorn Memorial Hospital.J Med Assoc Thai. 2006 Feb;89(2):138-44. J Med Assoc Thai. 2006. PMID: 16578998
-
Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.Int J Surg. 2008 Oct;6(5):382-6. doi: 10.1016/j.ijsu.2008.07.002. Epub 2008 Jul 16. Int J Surg. 2008. PMID: 18715834
Publication types
MeSH terms
LinkOut - more resources
Medical